Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer

NCT00181168 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00181168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00181168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2001
Completion date
September 30, 2003
Enrollment
63 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer